Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under regulation 30 of SEBI (LODR) Regulations, 2015 - Investors Earning Call recording09-02-2024
09-02-2024
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015 - Copy of Newspaper Publication of Unaudited Standalone & Consolidated Financial Results for the Quarter and Nine Months ended December 31, 202309-02-2024
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find the Investor Presentation on the financial highlights of the Company w.r.t the quarter ended on December 31, 2023.08-02-2024
Orchid Pharma Ltd - 524372 - Statement Of Deviation(S)/Variation(S) Of Issue Proceeds Under Regulation 32 Of Listing Regulation For The Quarter Ended On December 31, 2023.
Statement of Deviation(s)/Variation(s) under Regulation 32 of the Listing Regulations for the quarter ended on December 31, 2023.08-02-2024
Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Outcome Of The Board Meeting Held On February 08, 2024
Outcome of Board Meeting held on February 08, 202408-02-2024
Orchid Pharma Ltd - 524372 - Results-Financial Results For Quarter Ended On December 31, 2023
Financial Results for the Quarter ended on December 31, 202308-02-2024
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform that an investors earning call is schedule to be held on February 09, 2024 at 05:00 P.M. (IST) to discuss Financial performance of the Company for the quarter ended on December 31, 2023.05-02-2024
Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Holding Board Meeting On February 08, 2024
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 ,inter alia, to consider and approve Un-Audited Standalone & Consolidated Financial Results of the Company for the quarter ended on December 31, 2023 of the Financial Year 2023-24.02-02-2024
Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 30 Of Listing Regulations
This is to inform that "Orchid Pharmaceuticals SA stands deregistered vide certificate date January 31 2024 issued by CIPC South Africa.01-02-2024
Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Disclosure under regulation 30 of SEBI (LODR) Regulations, 2015 - Regarding the order passed by the Goods and Service Tax Department31-01-2024